BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2860828)

  • 1. Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis.
    Moss J
    Ann Fr Anesth Reanim; 1985; 4(2):221-4. PubMed ID: 2860828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased incidence and mortality of anaphylaxis to chymopapain.
    Moss J; Roizen MF; Nordby EJ; Thisted R; Apfelbaum JL; Schreider BD; McDermott DJ
    Anesth Analg; 1985 Dec; 64(12):1197-201. PubMed ID: 2865910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to chemonucleolysis: anesthetic considerations.
    Moss J; Roizen MF
    Int Anesthesiol Clin; 1985; 23(3):119-32. PubMed ID: 2863221
    [No Abstract]   [Full Text] [Related]  

  • 4. Repeat chemonucleolysis.
    Sutton JC
    Clin Orthop Relat Res; 1986 May; (206):45-9. PubMed ID: 2871956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine and antihistamines in anaphylaxis.
    Winbery SL; Lieberman PL
    Clin Allergy Immunol; 2002; 17():287-317. PubMed ID: 12113221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Premedication with H1- and H2-receptor antagonists for intravenous urography using contrast media].
    Reimann HJ; Tauber R; Kramann B; Gmeinwieser J; Schmidt U; Reiser M
    Rofo; 1986 Feb; 144(2):169-73. PubMed ID: 2869551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactions.
    Lieberman P
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):684-6. PubMed ID: 1977785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylaxis to chymopapain after antihistamine pretreatment.
    Levy JH
    Anesth Analg; 1985 Jan; 64(1):90. PubMed ID: 2857073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chymopapain allergy. Diagnostic value of a skin test before and after chemonucleolysis].
    Mayer HM; Brock M
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):51-6. PubMed ID: 3887196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anaphylactoid reactions following administration of plasma substitutes in man. Prevention of this side-effect of haemaccel by premedication with H1- and H2-receptor antagonists (author's transl)].
    Lorenz W; Doenicke A; Dittmann I; Hug P; Schwarz B
    Anaesthesist; 1977 Dec; 26(12):644-8. PubMed ID: 23706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H1 and H2 blockade: a prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity: Part II.
    Lorenz W; Doenicke A
    N Engl Reg Allergy Proc; 1985; 6(2):174-94. PubMed ID: 2442590
    [No Abstract]   [Full Text] [Related]  

  • 12. ["Rare" anaphylactoid reactions: can we learn anything from them?].
    Lorenz W
    Anaesthesist; 1985 Apr; 34(4):161-2. PubMed ID: 2860821
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Dolovich J; Schatz M; Zeiger R; Cogen F; Shaughnessy JJ; Chandler MJ
    Clin Orthop Relat Res; 1987 Aug; (221):202-6. PubMed ID: 3608299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chymopapain allergy: case reports and identification of patients at risk for chymopapain anaphylaxis.
    Grammer LC; Ricketti AJ; Schafer MF; Patterson R
    Clin Orthop Relat Res; 1984 Sep; (188):139-43. PubMed ID: 6380859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two anaphylactic deaths after chemonucleolysis.
    DiMaio VJ
    J Forensic Sci; 1976 Jan; 21(1):187-90. PubMed ID: 129501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs.
    Lorenz W; Doenicke A; Schöning B; Mamorski J; Weber D; Hinterlang E; Schwarz B; Neugebauer E
    Agents Actions; 1980 Apr; 10(1 Pt 2):114-24. PubMed ID: 6155762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymodiactin postmarketing surveillance. Demographic and adverse experience data in 29,075 patients.
    Agre K; Wilson RR; Brim M; McDermott DJ
    Spine (Phila Pa 1976); 1984; 9(5):479-85. PubMed ID: 6387953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic reactions following intradiscal injection of chymopapain under local anesthesia.
    Jacobs DM; Lipton MH; Russell SM
    J Bone Joint Surg Am; 1984 Jun; 66(5):806-7. PubMed ID: 6373775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histamine H1 and H2 receptor blockade as a supplementary premedication principle in elective surgery].
    Schöning B; Lorenz W; Doenicke A
    Schweiz Rundsch Med Prax; 1985 Mar; 74(13):315-22. PubMed ID: 2859648
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of histamine antagonists and agonists on IgE production in mice.
    Nakazawa T; Umegae Y
    Ann Allergy; 1992 Apr; 68(4):319-23. PubMed ID: 1373047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.